Artemisinin resistance in Plasmodium falciparum malaria
BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease. There are recent concerns that the efficacy of such therapies has declined on the Thai - Cambodian border, historically a site of emerging antima...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/27999 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.27999 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.279992018-09-13T13:57:37Z Artemisinin resistance in Plasmodium falciparum malaria Arjen M. Dondorp François Nosten Poravuth Yi Debashish Das Aung Phae Phyo Joel Tarning Khin Maung Lwin Frederic Ariey Warunee Hanpithakpong Sue J. Lee Pascal Ringwald Kamolrat Silamut Mallika Imwong Kesinee Chotivanich Pharath Lim Trent Herdman Sen Sam An Shunmay Yeung Pratap Singhasivanon Nicholas P.J. Day Niklas Lindegardh Duong Socheat Nicholas J. White Mahidol University Shoklo Malaria Research Unit Family Health International, Thailand Churchill Hospital National Center for Parasitology, Entomology and Malaria Control Institut Pasteur du Cambodge Organisation Mondiale de la Sante Medicine BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease. There are recent concerns that the efficacy of such therapies has declined on the Thai - Cambodian border, historically a site of emerging antimalarial-drug resistance. METHODS: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kilogram of body weight per day, for 7 days, and artesunate given at a dose of 4 mg per kilogram per day, for 3 days, followed by mefloquine at two doses totaling 25 mg per kilogram. We assessed in vitro and in vivo Plasmodium falciparum susceptibility, artesunate pharmaco kinetics, and molecular markers of resistance. RESULTS: We studied 40 patients in each of the two locations. The overall median parasite clearance times were 84 hours (interquartile range, 60 to 96) in Pailin and 48 hours (interquartile range, 36 to 66) in Wang Pha (P<0.001). Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloquine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), respectively, in Wang Pha (P = 0.31). These markedly different parasitologic responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative molecular correlates of P. falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]). Adverse events were mild and did not differ significantly between the two treatment groups. CONCLUSIONS: P. falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand. Resistance is characterized by slow parasite clearance in vivo without corresponding reductions on conventional in vitro susceptibility testing. Containment measures are urgently needed. (ClinicalTrials.gov number, NCT00493363, and Current Controlled Trials number, ISRCTN64835265.) Copyright © 2009 Massachusetts Medical Society. 2018-09-13T06:57:37Z 2018-09-13T06:57:37Z 2009-07-30 Article New England Journal of Medicine. Vol.361, No.5 (2009), 455-467 10.1056/NEJMoa0808859 15334406 00284793 2-s2.0-68049123592 https://repository.li.mahidol.ac.th/handle/123456789/27999 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=68049123592&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Arjen M. Dondorp François Nosten Poravuth Yi Debashish Das Aung Phae Phyo Joel Tarning Khin Maung Lwin Frederic Ariey Warunee Hanpithakpong Sue J. Lee Pascal Ringwald Kamolrat Silamut Mallika Imwong Kesinee Chotivanich Pharath Lim Trent Herdman Sen Sam An Shunmay Yeung Pratap Singhasivanon Nicholas P.J. Day Niklas Lindegardh Duong Socheat Nicholas J. White Artemisinin resistance in Plasmodium falciparum malaria |
description |
BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease. There are recent concerns that the efficacy of such therapies has declined on the Thai - Cambodian border, historically a site of emerging antimalarial-drug resistance. METHODS: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kilogram of body weight per day, for 7 days, and artesunate given at a dose of 4 mg per kilogram per day, for 3 days, followed by mefloquine at two doses totaling 25 mg per kilogram. We assessed in vitro and in vivo Plasmodium falciparum susceptibility, artesunate pharmaco kinetics, and molecular markers of resistance. RESULTS: We studied 40 patients in each of the two locations. The overall median parasite clearance times were 84 hours (interquartile range, 60 to 96) in Pailin and 48 hours (interquartile range, 36 to 66) in Wang Pha (P<0.001). Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloquine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), respectively, in Wang Pha (P = 0.31). These markedly different parasitologic responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative molecular correlates of P. falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]). Adverse events were mild and did not differ significantly between the two treatment groups. CONCLUSIONS: P. falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand. Resistance is characterized by slow parasite clearance in vivo without corresponding reductions on conventional in vitro susceptibility testing. Containment measures are urgently needed. (ClinicalTrials.gov number, NCT00493363, and Current Controlled Trials number, ISRCTN64835265.) Copyright © 2009 Massachusetts Medical Society. |
author2 |
Mahidol University |
author_facet |
Mahidol University Arjen M. Dondorp François Nosten Poravuth Yi Debashish Das Aung Phae Phyo Joel Tarning Khin Maung Lwin Frederic Ariey Warunee Hanpithakpong Sue J. Lee Pascal Ringwald Kamolrat Silamut Mallika Imwong Kesinee Chotivanich Pharath Lim Trent Herdman Sen Sam An Shunmay Yeung Pratap Singhasivanon Nicholas P.J. Day Niklas Lindegardh Duong Socheat Nicholas J. White |
format |
Article |
author |
Arjen M. Dondorp François Nosten Poravuth Yi Debashish Das Aung Phae Phyo Joel Tarning Khin Maung Lwin Frederic Ariey Warunee Hanpithakpong Sue J. Lee Pascal Ringwald Kamolrat Silamut Mallika Imwong Kesinee Chotivanich Pharath Lim Trent Herdman Sen Sam An Shunmay Yeung Pratap Singhasivanon Nicholas P.J. Day Niklas Lindegardh Duong Socheat Nicholas J. White |
author_sort |
Arjen M. Dondorp |
title |
Artemisinin resistance in Plasmodium falciparum malaria |
title_short |
Artemisinin resistance in Plasmodium falciparum malaria |
title_full |
Artemisinin resistance in Plasmodium falciparum malaria |
title_fullStr |
Artemisinin resistance in Plasmodium falciparum malaria |
title_full_unstemmed |
Artemisinin resistance in Plasmodium falciparum malaria |
title_sort |
artemisinin resistance in plasmodium falciparum malaria |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/27999 |
_version_ |
1763490910272749568 |